Background
Therapeutic footwear that includes either retail, custom-made or off-the-shelf footwear is recommended for patients with diseases such as rheumatoid arthritis (RA) as a beneficial intervention for reducing foot pain, improving foot health, and increasing general mobility [
1].
The foot is often the first area of the body to be systematically afflicted by RA [
2‐
4]. Seventy-five percent (75%) of patients with RA report foot pain within four years of diagnosis, with the degree of disability progressing with the course of the disease [
4]. Shi stated that virtually 100% of patients report foot problems within 10 years of disease onset [
5]. The management goals for the RA foot are pain reduction, the preservation of foot function, and improved patient mobility [
6].
A number of UK and European guidelines have recommended the use of therapeutic interventions for patients with RA [
7]. One national guideline in the UK reported that therapeutic footwear should be available to all people with RA, if indicated [
8]. In another UK study the authors reported that appropriate footwear for comfort, mobility and stability is well recognised in clinical practice but little available evidence for early RA [
9]. In established RA extra-width off-the-shelf therapeutic shoes for prolonged use are indicated when other types of footwear have failed [
10]. However, the level of supporting evidence is low, mainly at the 'good clinical practice' and 'expert opinion' agreement level [
7].
A limitation to current recommended guidelines is an assessment tool to evaluate footwear specifically for RA. In a recent article pertaining to falls prevention in older adults the authors reported that In order for health care professionals to accurately and efficiently critique an individual's footwear and provide advice, a valid and reliable footwear assessment tool is required [
11]. Such an assessment tool does not exist for footwear in patients with RA. The
Footwear Checklist provides guidance to health professionals when assessing patients' footwear but is not specific to RA [
12]. A
Footwear Assessment Tool based upon postural stability and falls risk factors has also been reported [
13]. The
Footwear Suitability Scale, a measure of shoe fit for people with diabetes has also been reported [
14].
To understand footwear characteristics determined by patients with RA, the aims of the study were to identify footwear style, footwear characteristics, and key factors influencing footwear choice using objective footwear assessment tools.
Discussion
The aim of this study was to identify current footwear styles, footwear characteristics, and factors that influence footwear choice experienced by patients with RA. Overall, we found that moderate impairment and limited activity scores, consistent with significant foot disability. Foot deformities such as bunions were present in over 50% of patients with a low-arch profile. Forefoot structural deformities were high, suggesting that patients have problems in finding good footwear that accommodates structural changes in the forefoot and lesser extent in the rearfoot. Previous studies have also highlighted the problems of forefoot deformities in rheumatoid patients [
23,
24]. Helliwell further stated that patients with foot deformity find it increasingly difficult to buy footwear that can accommodate their foot shape as deformity progresses [
23]. Difficulties in finding appropriate footwear due to forefoot structural deformities and the consequence wearing of inappropriate footwear can be a major contributing factor to foot impairment.
We found that the majority of patients were wearing court-shoes, sandals, moccasins, mules and jandals [jandals are specifically known to New Zealanders and other countries describe them as flip-flops or thongs]. One study reported that gait changes were observed in asymptomatic population with wearing flip-flops in and suggested that the shoe construction may contribute to lower limb leg pain and are counter-productive to alleviating pain [
25]. The wearing of open-type footwear should be interpreted with caution. It is important to understand that open-type footwear, such as jandals and sandals are commonly worn in New Zealand, and the study was conducted during the summer. Future studies classifying footwear in patients with RA needs to take into cultural differences. Court-shoes were considered 'poor' due to lack of support mechanisms, cushioning and protection of toe regions possibly contributing to impairment and disability. Dixon argued that some of the foot deformities observed in RA, are the result of wearing of poor shoes, such as court shoes, although the authors do not substantiate this statement with any evidence [
26].
The patients' choice of wearing athletic footwear in the current study reflects similar findings from a previous study that reports younger patients with RA (average age 58 years old) being prescribed athletic footwear as being 'acceptable', compared with off-the shelf orthopaedic footwear [
27]. Helliwell also reported that many RA patients find athletic shoes the most comfortable option [
23]. As the disease progresses the desire is to find wider fitting shoes to accommodate the broadening forefoot is needed and this is reflected in the high forefoot structural index score found in the current study. However, it is also reported that people with RA desire a choice in footwear according to their needs, particularly social needs and requirement in relation to seasonal variations [
1]. Footwear such as therapeutic footwear or trainers may not meet those needs and this may be reflected in the current study in the higher use of sandals.
Despite the benefits of therapeutic footwear that have been previously reported [
9,
28‐
31], this type of footwear was not widely worn by patients in the current study. Additionally there are known factors relating to poor use of therapeutic footwear related to many factors that deem it unacceptable [
1,
32,
33]. Williams identified therapeutic footwear as being the only intervention that we give that replaces something that is normally worn as an item of clothing and therefore reinforces the stigma of foot deformity and disability [
1]. In addition to the body image issues Otter reported that that some patients discontinued using therapeutic footwear either because their foot symptoms had resolved or because they had foot surgery [
32].
In the current study the participants reported that fit and comfort were important factors in choosing footwear, suggesting that patients prioritise fit due to their long-term disability. These findings are consistent with other reports [
22]. Williams reported on the perception of features of five different pairs of off the shelf footwear [
22]. Each patient was asked to examine the shoes and was then interviewed. Questions were asked about overall comfort, shoe style and fit. The results from interviews showed that in the rheumatoid group comfort was the primary factor followed by style and fit. Helliwell [
23] has suggested that once the disease progresses the resulting pain and ensuing deformity makes obtaining comfortable footwear that fits a difficult task. Although patient's preference was for a 'poor' type of shoe, however, they reported them to be comfortable. This seems counter-intuitive and taken at face value perhaps there is a need to re-consider how footwear is classified. If 'poor' footwear is the most comfortable, much footwear advice given by health professionals may need re-evaluated and describing appropriate or good footwear should be incorporated into any short or long term management strategies.
In relation to the footwear characteristics we found that the majority of patients wore shoes that had an adequate heel height. On examining the fastening mechanism of the footwear, one strap/buckle was found in nearly 50% of shoes, possibly due to hand deformities that are often observed in patients with established RA may have contributed to the low number of shoes that used laces. Wear patterns on the footwear provided some indication in nearly 50% that they were partially worn. This aligns with comments made by the participants in relation to their choice of footwear for comfort and fit. Other footwear characteristics produced inconclusive results suggesting that the current assessment tool used in this study was not suitable for assessing footwear in patients with RA.
There are several limitations to this study that warrant discussion. The patients were recruited from one large city hospital during the summer months. The findings may not be a true representation of footwear styles in rural settings or during cooler seasons. A long term multicentre study is required to demonstrate geographical and seasonal differences in patients' preference of footwear style and type. The current study used a self-reported questionnaire to identify footwear style based upon postural stability and falls prevention. Future work needs to aim to define and justify the specific features of footwear that may be of benefit to foot health for people with RA in relation to their needs.
An important factor that was not included into the current study was direct or indirect costs. The wearing of poor shoes may have been due to financial constraints of purchasing 'good' footwear, i.e. direct costs to the patients. Furthermore, RA is a painful and distressing condition that can affect all ages and have a major impact on economically active adults, who may be forced to give up work either temporarily or permanently due to their condition, i.e. indirect costs. Therefore, clinicians and researchers should be aware of the direct and indirect costs to patients in obtaining 'good; footwear.
Secondary analysis demonstrated a significant correlation between footwear type and forefoot deformities using the Foot Structural Index. Tentatively, this suggests a link between presence of forefoot deformities and footwear. Since the majority of RA patients suffer from forefoot deformities, difficulties in finding 'good; footwear may exacerbate the already existing problems. The index is a qualitative tool providing an overall observation of forefoot and rearfoot deformities in quick and easy manner. However, the index has not been evaluated for its reliability. Helliwell [
23] also reported that the index is limited to monitor subtle changes of foot deformity over time. Furthermore, the current study was cross-sectional. Future studies need to evaluate cause and effect before any definitive conclusions can be made looking at the relationship between footwear, foot type, foot pathologies and associated pain.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
KR and ND conceived and designed the study. RS collected and inputted the data. KR and RS conducted the statistical analysis. KR and RS compiled the data and drafted the manuscript and RS, ND and AW contributed to the drafting of the manuscript. All authors read and approved the final manuscript.